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Previewstalin head region but Elliott et al. (2010)
achieved success by removing the flex-
ible F1 insertion. Their data from the
crystal structure were supplemented by
X-ray scattering and NMR studies on the
intact head. The results suggest that the
F0-F1 and F2-F3 subdomain pairs form
relatively rigid structures, while the F1-
F2 linker is flexible.
The F3 subdomain, which can be
classified as a PTB (phospho-tyrosine
binding) domain, is often the key binding
site for FERM domain interactions with
other proteins; talin F3 is no exception,
as shown by its ability to bind to b-integrin
tails. A basic patch on the F2 subdomain
docks on the membrane, helping to
orient the membrane-spanning helix of
the b-integrin subunit and to promote
separation of the a and b integrin subunits
(Anthis et al., 2009) (Figure 1). Elliott et al.
(2010) show here that the positive patch
on F2 and the positively charged F1 inser-
tion loop facilitate cell spreading in cells
transfected with modified talin heads.
The extended conformation of the talin
head thus seems to have evolved to
bind both to integrins, via F3, and to nega-
tively charged microdomains in the lipid
bilayer (Figure 1).A number of other interesting features
emerge from the new talin head structure.
FERM domain activity is often regulated
by various inter- and intramolecular inter-
actions (Fehon et al., 2010). Talin is also
autoinhibited by intermolecular associa-
tion between the F3 subdomain and
a helical bundle in the rod region (Goksoy
et al., 2008; Goult et al., 2009a). The new
structure shows that this interaction
would not only mask the integrin binding
site in F3, but also prevent the F2 and F3
domains interacting with the membrane;
the structure suggests, however, that the
F1 and F0 domains would be still be able
to locate the autoinhibited talin within the
membrane.
The kindlin family of proteins, which
assist talin in activating integrins (Moser
et al., 2009), have FERM domains with
talin-like features, such as an N-terminal
F0 domain, a large F1 loop (Goult et al.,
2009b), and an F1-F2 linker that is
predicted to be flexible. This sug-
gests that the subdomain arrangement
seen in the talin FERM domain may
not be an unusual outlier; it may be
the first of a number of proteins with
this noncanonical arrangement of sub-
domains.Structure 18, October 13, 2010 ªREFERENCES
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In this issue, Yu et al. (2010) provide a crystal structure for the bipartite interface between the m2 subunit of the
adaptor protein AP-2 complex and Dishevelled, a key component for Wnt signaling.Secreted Wnt proteins regulate embryo-
genesis and homeostasis by activating
multiple intracellular signaling pathways,
including the canonical b-catenin and the
noncanonical planar cell polarity (PCP)
pathways. Frizzled (Fz) proteins, the main
type of Wnt receptors, together with other
coreceptors mediate activation of the
Wnt/b-catenin and/or PCP pathways.
The cytoplasmic Dishevelled (Dvl) proteinis required downstreamofWnt/Fz for both
these pathways (Gao and Chen, 2010;
MacDonald et al., 2009). But how Dvl acti-
vates these distinct downstream path-
ways remains enigmatic. Some recent
insights, including a report in this issue
of Structure (Yu et al., 2010), help to
shed light on this long-standing question.
Dvl is a scaffold protein containing
three highly conserved domains: DIX(Dishevelled/Axin), PDZ (PSD-95, DLG,
ZO1), and DEP (Dishevelled, EGL-10,
Pleckstrin) (Gao and Chen, 2010). Sim-
plistically speaking, the N-terminal DIX
domain of Dvl functions mainly in canon-
ical signaling, and the central PDZ domain
is required in both pathways via interac-
tion with the cytoplasmic tail of Fz, while
the more carboxyl DEP domain is critical
for PCP signaling via mediation of the2010 Elsevier Ltd All rights reserved 1223
Figure 1. Fz/Dvl/AP-2/Membrane Interactions in PCP Signaling
The DEP domain participates in Dvl recruitment to the plasmamembrane via a positively charged surface,
which interacts with negatively charged lipids in the inner plasma membrane, and via a surface encom-
passing the conserved lysine (K) and tyrosine (Y) residues (K417 and Y473 in Drosophila Dsh), which
may interact with an unknown protein. Dvl binds to m2 primarily via the YHEL motif and in addition via
a surface in the DEP domain. The AP-2 complex is recruited and converted to an open (active) conforma-
tion via interacting with PIP2 (red colored lipids) and possibly with Dvl. The PDZ domain binds to Fz
C terminus, whereas the DIX domain may mediate homo-oligomerization. a and s2 subunits in the
AP-2 complex and other components in the Fz/Dvl complex are omitted for clarity. See text for details.
Structure
PreviewsDvl cytoplasmic-to-membrane transloca-
tion. Recent advances have led to new
working models for Dvl in these distinct
Wnt/Fz signaling events. Wnt/b-catenin
signaling relies on DIX-domain dependent
Dvl polymerization (punta formation),
which may help to promote the clustering
of Fz and its coreceptor LRP6, leading to
the formation of a supercomplex (signalo-
some) that consists of Wnt-Fz-LRP6-Dvl,
and Axin, a key scaffolding protein for
b-catenin regulation (MacDonald et al.,
2009). Dvl is highly dynamic; it gets in
and out of this supercomplex rapidly.
In contrast, in the PCP pathway, which
does not directly involve LRP6 and
Axin functions, persistent association
of Dvl with the plasma membrane
appears to be vital and the DEP domain
plays a crucial role in this process. The
DEP domain-mediated plasma mem-
brane association appears to involve mul-
tiple distinct, perhaps synergistic, molec-
ular interactions. One is the electrostatic
attraction between a positively charged
surface of the DEP domain with the nega-
tively charged lipids of the inner layer of
the plasma membrane (Wong et al.,
2000) (Figure 1). This interaction is sensi-
tive to the intracellular pH, which is in
part maintained by the Na+/H+ exchanger
Nhe2 (Simons et al., 2009).
Another important interaction, which
Yu et al. (2010) address in this issue, is
the direct binding between Dvl and m2,
a subunit of the clathrin adaptor protein
complex AP-2, which is composed of a,
b2, s2, and m2 subunits (Owen et al.,
2004). This interaction is required for cla-1224 Structure 18, October 13, 2010 ª2010 Ethrin-mediated endocytosis of Fz and Dvl
upon Wnt activation and is important for
PCP signaling (Yu et al., 2007). The inter-
action between Dvl and AP-2 is bipartite
and requires simultaneous association of
the DEP domain plus an YHELmotif within
Dvl to the C-terminal region of m2 (m2C)
(Yu et al., 2007). The YHEL motif, located
60 residues C-terminal to the DEP
domain in Dvl2, resembles a classical en-
docytic YxxF motif found in many m2C-
binding proteins (Owen et al., 2004). Yu
et al. (2010) solved the crystal structure
of m2C in complex with a DEP-YHEL frag-
ment from Dvl2, one of the three mamma-
lian Dvl proteins. In the structure, the DEP
domain binds at one end of the elongated
m2C, whereas the YHEL motif binds to
a separate groove on the m2C surface,
with the sequence between DEP and
YHEL likely being flexible (Figure 1).
The AP-2 adaptor can exist in either
closed (inactive) or open (active) confor-
mation (Jackson et al., 2010). The large
conformational change from the closed
to the open conformation involves a relo-
cation of m2C to an orthogonal face of
AP-2, and an unstructured m2 linker
between the N- and C-terminal halves
becomes helical and binds back onto
the AP-2 complex in the process (Jackson
et al., 2010). It has been suggested
that this conformational change is mainly
driven by the simultaneous binding
of phosphatidylinositol 4,5-bisphosphate
(PtdIns(4,5)P2 or PIP2), which is enriched
in the plasma membrane, by the a, b2,
and m2 subunits, and by phosphorylation
of the m2 linker region (Jackson et al.,lsevier Ltd All rights reserved2010). While the DEP domain can interact
with both the open and closed conforma-
tions of AP-2, the YHEL motif, which
provides the majority of the binding
affinity of Dvl for AP-2, may only interact
with the open conformation (Yu et al.,
2010). In principle, the DEP domain,
despite of its low affinity without the
YHEL motif, may play a role in the open-
close conformational equilibrium of AP-2
near the plasma membrane. One may
speculate that once both the DEP domain
and the YHELmotif bind to the AP-2 open
conformation, the Dvl/AP-2 complex is
stabilized and Fz/Dvl endocytosis will
ensue (Figure 1).
Do the positively charged and m2C-
binding surfaces account fully for Dvl
membrane association? The answer is
probably no. A well-known Drosophila
Dishevelled (referred to as Dsh) mutant
allele (dsh1) (Axelrod et al., 1998) causes
a lysine (K417) to methionine (M) mis-
sense mutation in the DEP domain and
exhibits defective function in PCP but
normal function in Wnt/b-catenin sig-
naling. This Dsh K to M mutant shows
profound deficiency in membrane locali-
zation (Axelrod et al., 1998), but caused
only marginal effect on Dvl/AP-2 binding
in vitro (Yu et al., 2007, 2010). Indeed,
this lysine residue belongs to neither the
positively charged nor the m2C-binding
surface (despite of being close to the
latter). More recently, it was shown that
the Drosophila Abl tyrosine kinase regu-
lates PCP signaling by phosphorylating
Dsh at a tyrosine (Y473) of the DEP
domain, and a point mutation (Y473F)
abolishes Dsh membrane localization
(Singh et al., 2010). It is interesting that
Y473 is also not a part of the above two
identified surfaces but instead is spatially
close to K417 (Figure 1). Thus, it is likely
that a third surface in the DEP domain,
encompassing K417 and Y473 in Dsh,
participates in Dvl membrane recruitment
during PCP signaling via interacting with
yet another factor, which remains to be
identified.
Multiple surfaces, including m2C-
binding and membrane-binding surfaces
on the DEP domain, may help to explain
how Dvl is recruited to the plasma mem-
brane and PCP signaling is achieved.
These molecular interactions, together
with the PDZ-mediated binding of Dvl to
Fz, bring Dvl and AP-2 into the proximity
of the Wnt receptor complex, initiating
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Previewspresumably Fz endocytosis and signaling
(Figure 1). Note that PIP2 has a key role in
recruiting and converting AP-2 from the
inactive (closed) to the active (open)
form at the plasma membrane (Jackson
et al., 2010). It has been reported that
Wnt stimulates the production of PIP2
through Fz and Dvl, which activates lipid
kinases PI4K and PIP5K (MacDonald
et al., 2009; Qin et al., 2009). Although
this Fz-Dvl induced PIP2 production has
only been implicated in Wnt/b-catein
signaling thus far, the possibility that it
also accounts for, together with direct
Dvl-binding, AP-2 recruitment to the Fz
complex during PCP signaling deserves
consideration.
Have we arrived at the juncture where
we can explain Dvl specificity in Wnt/
b-catenin and PCP signaling? Unfortu-
nately not. In fact, some recent studies
added more weight to the argument that
the simple notion that the DIX and DEP
domains are specific for Wnt/b-catenin
and PCP signaling, respectively, might
be too simple after all. First, the DEP
domain may have important contributions
to Wnt/b-catenin signaling, for example,
through the aforementioned positivelycharged surface (Simons et al., 2009)
and binding/activating PI4K for PIP and
PIP2 production (Qin et al., 2009). Second,
the DIX domain-mediated Dvl polymeriza-
tion can be regulated by both canonical
and noncanonical Wnt signaling, and
intriguingly by the DEP domain (specifi-
cally the K to M mutation) during nonca-
nonical signaling (Nishita et al., 2010).
Therefore it appears that intramolecular
interactions among different Dvl domains
in Wnt pathways are elaborate and
perhaps regulated, contributing to the
activation of specific downstream events.
The molecular insights on Dvl/AP-2 inter-
action (Yu et al., 2010) help to define
a role of Dvl in PCP signaling, and in addi-
tion, as the authors pointed out, suggest
that the bipartite/combinatory interaction
may be a common theme in cargo/AP-2
coupling.REFERENCES
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The dynamic properties of VDR LBD and full-length VDR/RXRa heterodimer in the presence and absence of
ligands were investigated by hydrogen/deuterium exchange mass spectrometry (Zhang et al., 2010a). The
results beautifully complement X-ray crystal structure data.Nuclear receptors (NRs) exist in a cell inte-
rior and are responsible for sensing the
presence of various molecules, including
steroid and thyroid hormones (Olefsky
and Saltiel, 2000). NRs are one of the
largest classes of drug targets along with
G protein-coupled receptors (GPCRs)
and ion channels. Detailed studies of
NRs are critical not only for understanding
biology but also for the development of
therapeutic agents.Visualization of a protein structure enor-
mously helps our understanding of the
mechanism and function of the protein.
A crystal structure of drug target protein
is the basis of structure-based drug
design. X-ray crystallography is one of
the most powerful driving forces of
modern biology and medicine, though
there are limitations. One limitation is its
applicability. Not all drug targets are crys-
tallizable, let alone all the complexesinvolving drug targets. The other issue is
the static nature of the information
obtained. An X-ray crystal structure of
a protein is a high-resolution snapshot of
a dynamic entity. To fully describe the
protein, it is desirable to obtain the
dynamic characteristics of the protein in
addition to the static structural informa-
tion.
Amide hydrogen/deuterium exchange,
when coupled with proteolysis and mass2010 Elsevier Ltd All rights reserved 1225
